Fennec Pharmaceuticals Inc. (TSX:FRX)

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had revenue of $9.65M USD in the quarter ending June 30, 2025, with 32.91% growth. This brings the company's revenue in the last twelve months to $33.30M, down -31.88% year-over-year. In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M with 123.69% growth.

• Revenue (ttm): $33.30M
• Revenue Growth: -31.88%
• P/S Ratio: 7.80
• Revenue / Employee: $1.04M
• Employees: 32
• Market Cap: 346.40M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.54M	26.29M	123.69%
Dec 31, 2023	21.25M	19.72M	1,284.50%
Dec 31, 2022	1.54M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	170.00K	-	-